Effectiveness of Heterologous and Homologous Ad26.COV2.S Vaccine Boosting in Preventing COVID-19-Related Outcomes Among Individuals with a Completed Primary Vaccination Series in the United States

<b>Background/Objectives:</b> COVID-19 vaccines have significantly reduced the mortality and morbidity associated with SARS-CoV-2. In the fall of 2021, the U.S. Food and Drug Administration amended its emergency use authorization guidelines for COVID-19 vaccines to allow the administrati...

Full description

Bibliographic Details

Published in:	Vaccines
Main Authors:	Mawuli Nyaku, Lara S. Yoon, Deborah Ricci, Lexie Rubens, Paige Sheridan, Monica Iyer, Thomas Zhen, Raymond A. Harvey, Ann Madsen
Format:	Article
Language:	English
Published:	MDPI AG 2025-02-01
Subjects:	COVID-19 adenovirus vaccine booster vaccine real-world data real-world evidence
Online Access:	https://www.mdpi.com/2076-393X/13/2/166